FIELD: chemistry.
SUBSTANCE: compound has general formula (where R1 and R3 are identical or different, and each denotes a hydrogen atom or C1-6alkyl; R2 denotes, for example, 5,5-dimethyl-1,3-dioxan-2-yl, 5,7-dioxaspiro[2.5]oct-6-yl, 1,5,9-trioxaspiro [5.5]undec-3-yl, 2,2-dimethyl-1,3-dioxan-5-yl etc; R4, R5, R6 and R7 each denotes a hydrogen atom, a halogen atom, C1-6 alkyl, C1-6 halogenalkyl, C1-6 alkoxy, C1-6 halogenalkoxy etc, and W1 denotes a single bond, methylene or ethylene, or salt thereof.
EFFECT: compound has excellent inhibiting activity towards secretion of gastric hydrochloric acid and more effectively in preserving inhibiting activity towards secretion of gastric hydrochloric acid, can maintain pH in the stomach for a long period of time, is safe and has acceptable physical and chemical resistance.
40 cl, 4 tbl, 97 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOPYRIDINE COMPOUND | 2005 |
|
RU2373206C2 |
PYRIDYLOXY DERIVATIVES EFFECTIVE AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA ACTIVATOR/MODULATOR | 2010 |
|
RU2480463C1 |
BENZIMIDAZOLE DERIVATIVES, BASED PHARMACEUTICAL COMPOSITION AND METHODS OF USING THEM | 2008 |
|
RU2456276C2 |
PIRAZOLOQINOLINE DERIVATIVE | 2012 |
|
RU2605096C2 |
CONDENSED HETEROCYCLIC COMPOUNDS | 2006 |
|
RU2408586C2 |
HETEROCYCLIC COMPOUND | 2006 |
|
RU2382781C2 |
NEW DERIVATIVE OF 3-AZABICYCLO[3.1.0]HEXANE AND USE THEREOF FOR MEDICAL PURPOSES | 2014 |
|
RU2701861C1 |
CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
THIAZOLYLPHENYL-BENZENESULFONAMIDO DERIVATIVES AS KINASE INHIBITORS | 2012 |
|
RU2606497C2 |
Authors
Dates
2011-01-20—Published
2006-04-17—Filed